GlassScriptPhysician profile
Jonathan L Chin
NPI 1841216892
$2,677.14
in general payments reported to CMS, 2019-2025
22 companies · $549 in 2025
The $549 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $418 · 2020: $432 · 2021: $289 · 2022: $181 · 2023: $308 · 2024: $501 · 2025: $549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,357.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $613.21 | 2022-2025 | Botox, Lupron Depot |
| Neotract INC. | $579.59 | 2019-2020 | |
| Teleflex LLC | $569.16 | 2021-2025 | Urolift |
| Allergan, INC. | $119.84 | 2019-2021 | |
| Olympus America INC. | $98.90 | 2019-2025 | Itind System |
| Accord Healthcare, INC. | $98.42 | 2024-2025 | |
| Abbott Laboratories | $95.68 | 2021 | |
| Astellas Pharma US INC | $80.90 | 2020-2022 | |
| Pfizer INC. | $68.29 | 2019-2024 | |
| Ferring Pharmaceuticals INC. | $61.79 | 2020-2025 | Adstiladrin |
| Antares Pharma, INC. | $58.81 | 2019 | |
| Bluewind Medical | $48.15 | 2025 | Revi |
| Myriad Genetic Laboratories, INC. | $24.79 | 2022 | |
| Palette Life Sciences, INC. | $24.22 | 2023 | |
| Boston Scientific Corporation | $21.90 | 2024 | Greenlight Xps |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $20.62 | 2021 | |
| Telix Pharmaceuticals | $16.11 | 2023 | Illuccix |
| Dentsply Ih INC. | $16.10 | 2020 | |
| Ambu INC. | $16.04 | 2025 | |
| Avadel Specialty Pharmaceuticals, LLC | $15.75 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $14.50 | 2019 | |
| Laborie Medical Technologies Corp. | $14.37 | 2024 | Eclipse |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Chin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.